
KAT6A Syndrome - Symptoms, Causes, Treatment | NORD
2023年6月15日 · KAT6A syndrome is an extremely rare genetic neurodevelopmental disorder in which there is a variation (mutation) in the KAT6A gene. Variations in the KAT6A gene can …
What is KAT6A Syndrome? - KAT6 Foundation
KAT6A syndrome, also known as Arboleda-Tham Syndrome (ARTHS), is a rare disorder resulting from a mutation in the KAT6A gene. Through genetic research, we have learned that the …
KAT6A - Wikipedia
Arboleda-Tham syndrome (ARTHS), [10] also referred to as KAT6A Syndrome (Arboleda-Tham Syndrome), is a rare autosomal dominant developmental disorder, caused by various …
KAT6 Foundation | Support, Treatment & Research
The KAT6 Foundation supports people and their families who are living with KAT6A and KAT6B syndromes around the world. We advance scientific research aimed at developing treatments …
KAT6A Gene - GeneCards | KAT6A Protein | KAT6A Antibody
2025年3月30日 · KAT6A (Lysine Acetyltransferase 6A) is a Protein Coding gene. Diseases associated with KAT6A include Arboleda-Tham Syndrome and Syndromic Intellectual …
What is KAT6A syndrome? KAT6A syndrome is a rare genetic condition that results from ‘spelling mistakes’ (aka mutations) in a gene called KAT6A. (The KAT6A gene is located on the short …
Targeting KAT6A/B as a New Therapeutic Strategy for Cancer …
2025年1月6日 · KAT6A is an oncogene in human acute myeloid leukemia (AML), and KAT6A overexpression in AML is associated with metastases and poor prognoses. Furthermore, …
Studying KAT6A and KAT6B gene function will increase our overall knowledge of multiple systems in the body to unlock the possibility for greater health for all. Children with KAT6 …
The key roles of the lysine acetyltransferases KAT6A and KAT6B in ...
In the current review, we discuss the physiological functions of the acetyltransferases KAT6A and KAT6B as well as their functions under pathological conditions of aberrant expression, leading …
Inhibitors of histone acetyltransferases KAT6A/B induce ... - Nature
2018年8月1日 · Here we present highly potent, selective inhibitors of KAT6A and KAT6B, denoted WM-8014 and WM-1119. Biochemical and structural studies demonstrate that these …